Literature DB >> 17586538

Commentary: Observational studies and the art of accurately measuring influenza vaccine benefits.

Lone Simonsen1.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17586538     DOI: 10.1093/ije/dym084

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


× No keyword cloud information.
  6 in total

1.  Statement on Seasonal Influenza Vaccine for 2011-2012: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2011-10-14

2.  Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2010-2011: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2010-08-31

3.  STATEMENT ON SEASONAL INFLUENZA VACCINE FOR 2012-2013: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2012-08-01

4.  Statement on Seasonal Influenza Vaccine for 2013-2014: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2013-10-10

5.  Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study.

Authors:  Anneke Steens; Eleonora G Wijnans; Jeanne P Dieleman; Miriam Cjm Sturkenboom; Marianne Ab van der Sande; Wim van der Hoek
Journal:  BMC Infect Dis       Date:  2011-07-18       Impact factor: 3.090

6.  Seasonal Influenza Vaccine Effectiveness in the community (SIVE): protocol for a cohort study exploiting a unique national linked data set.

Authors:  Nazir I Lone; Colin Simpson; Kimberley Kavanagh; Chris Robertson; Jim McMenamin; Lewis Ritchie; Aziz Sheikh
Journal:  BMJ Open       Date:  2012-03-15       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.